Total Laboratory Automation: What Is Gained, What Is Lost, and Who Can Afford It?

Richard B. Thomson, Erin McElvania

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

The first clinical microbiology laboratory in the United States adopted total automation for bacteriology processing in 2014. Since then, others have followed with installation of either the BD Kiestra TLA or the Copan WASPLab. This article discusses commercially available automated systems in the United States; why automation is needed; and quality improvements, efficiency, and cost savings associated with automation. After learning how these systems are used, gains and losses experienced, and how one can afford the most expensive equipment ever purchased for clinical microbiology laboratories, the question is, how can one afford not to purchase one of these microbiology automation systems?

Original languageEnglish (US)
Pages (from-to)371-389
Number of pages19
JournalClinics in laboratory medicine
Volume39
Issue number3
DOIs
StatePublished - Sep 1 2019
Externally publishedYes

Keywords

  • BD Kiestra TLA
  • Copan WASPLab
  • Microbiology automation
  • Microbiology cost savings
  • Microbiology efficiency
  • Microbiology quality

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Total Laboratory Automation: What Is Gained, What Is Lost, and Who Can Afford It?'. Together they form a unique fingerprint.

  • Cite this